SCHEMBL7187866

SCHEMBL7187866

CCCc1ccc(OC(C)C)c(/C=C/C(=O)c2ccc(NC)cc2)c1OC(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
ABCG2 Q9UNQ0 5/20 0.36
CYP3A4 P08684 2/20 0.35
MAPT P10636 5/20 0.34
NPSR1 Q6W5P4 3/20 0.34
RAB9A P51151 1/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
LMNA P02545 3/20 0.33
TUBB4A P04350 2/20 0.33
TUBB P07437 2/20 0.33
TUBA3C P0DPH7 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7187869 1.00 PDE4A (0.36) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL7189611 0.88 ABCG2 (0.42) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL7189608 0.88 ABCG2 (0.42) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL7185124 0.87 CA1 (0.42) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL7185126 0.87 CA1 (0.42) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL7804192 0.87 PTPN1 (0.42) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL7804196 0.87 PTPN1 (0.42) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL7184272 0.85 ALDH1A1 (0.37) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL7184268 0.85 ALDH1A1 (0.37) PDE4APDE4BPDE4CPDE4DABCG2
SCHEMBL7179804 0.85 ABCG2 (0.40) PDE4APDE4BPDE4CPDE4DABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed